Notable mutations driving these tumours include the KIAA1549‐BRAF fusion, which is common in pilocytic astrocytoma (approximately 70%) and rosette‐forming glioneural tumours (around 30%) in non‐NF1 cases. Here, BRAF is linked to neoplasm.